Article Information
History
- September 5, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Ausenda Machado*,1,a,b,
- Irina Kislaya1,a,
- Patricia Soaresa,b,
- Sarah Magalhãesc,
- Ana Paula Rodriguesa,
- Rafael Francoc,
- Pedro Pinto Leited,
- Carlos Matias Diasa,b and
- Baltazar Nunesa,b
- aInstituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal
- bCentro de Investigação em Saúde Pública, Universidade NOVA de Lisboa, Lisbon, Portugal
- cServiços Partilhados do Ministério da Saúde, Lisbon, Portugal
- dDireção-Geral da Saúde, Lisbon, Portugal
- ↵*Corresponding author: Ausenda Machado - Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge, Lisbon, Portugal, Avenida Padre Cruz, phone number 00351 217526491, e-mail: ausenda.machado{at}insa.min-saude.pt
↵1 These first authors contributed equally to this article
Posted September 05, 2023.
Bivalent mRNA vaccine effectiveness against COVID-19 infections, hospitalisations and deaths in Portugal: a cohort study based on electronic health records, September 2022 to May 2023
